SEC Filings

SEC Filings

Filing date	Description	Form	View
Nov 02, 2010	Statement of changes in beneficial ownership of securities	4	View HTML 0001181431-10-053010.pdf 0001181431-10-053010.rtf
Nov 02, 2010	Statement of changes in beneficial ownership of securities	4	View HTML 0001181431-10-053011.pdf 0001181431-10-053011.rtf
Nov 01, 2010	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-10-241995.pdf 0001193125-10-241995.rtf 0001193125-10-241995.xls
Nov 01, 2010	Amendment to a previously filed SC TO-I	SC TO-I/A	View HTML 0001193125-10-241999.pdf 0001193125-10-241999.rtf 0001193125-10-241999.xls
Oct 29, 2010	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-10-240980.pdf 0001193125-10-240980.rtf 0001193125-10-240980.xls
Oct 25, 2010	Amendment to a previously filed SC TO-I	SC TO-I/A	View HTML 0001193125-10-235092.pdf 0001193125-10-235092.rtf 0001193125-10-235092.xls
Oct 22, 2010	Additional proxy soliciting materials - definitive	DEFA14A	View HTML 0001193125-10-234623.pdf 0001193125-10-234623.rtf 0001193125-10-234623.xls
Oct 22, 2010	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-10-234627.pdf 0001193125-10-234627.rtf 0001193125-10-234627.xls
Oct 21, 2010	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-10-233174.pdf 0001193125-10-233174.rtf 0001193125-10-233174.xls
Oct 20, 2010	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-10-232216.pdf 0001193125-10-232216.rtf 0001193125-10-232216.xls

Data provided by Kaleidoscope.

For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE